Gravitate Health FHIR Implementation Guide
0.1.0 - CI Build
Gravitate Health FHIR Implementation Guide
0.1.0 - CI Build
Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health/ and changes regularly. See the Directory of published versions
<Bundle xmlns="http://hl7.org/fhir">
<id value="bundlepackageleaflet-en-a64c0ccb066e7fdf6ba2d86dcd8bda5e"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Bundle-uv-epi"/>
</meta>
<language value="en"/>
<identifier>
<system value="https://www.gravitatehealth.eu/sid/doc"/>
<value value="gh-1"/>
</identifier>
<type value="document"/>
<timestamp value="2023-06-27T10:09:22Z"/>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/Composition/composition-en-04c5df8b1b688f62331c672bbd9ffa97"/>
<resource>
<Composition>
<id value="composition-en-04c5df8b1b688f62331c672bbd9ffa97"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Composition-uv-epi"/>
</meta>
<language value="en"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><a name="Composition_composition-en-04c5df8b1b688f62331c672bbd9ffa97"> </a><p><b>Generated Narrative: Composition</b><a name="composition-en-04c5df8b1b688f62331c672bbd9ffa97"> </a><a name="hccomposition-en-04c5df8b1b688f62331c672bbd9ffa97"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceComposition "composition-en-04c5df8b1b688f62331c672bbd9ffa97" (Language "en") </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Composition-uv-epi.html">Composition (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/rmswi/</code>/462b3fc5470f43286799c472a0c8554e</p><p><b>status</b>: final</p><p><b>type</b>: Package Leaflet <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#100000155538)</span></p><p><b>category</b>: Raw <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="CodeSystem-epicategory-cs.html">Category of EPI</a>#R)</span></p><p><b>date</b>: 2022-02-16 13:28:17+0000</p><p><b>author</b>: See on this page: Organization/mah-d21dfe8c15312e8b8bf0b7774b510a9d</p><p><b>title</b>: TEST PURPOSES ONLY - Calcichew-D3 Forte</p><h3>Attesters</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Mode</b></td><td><b>Time</b></td></tr><tr><td style="display: none">*</td><td>Official <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-composition-attestation-mode.html">Composition Attestation Mode</a>#official)</span></td><td>2022-02-16 13:28:17+0000</td></tr></table></div>
</text>
<identifier>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<value value="462b3fc5470f43286799c472a0c8554e"/>
</identifier>
<status value="final"/>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<code value="100000155538"/>
</coding>
<text value="Package Leaflet"/>
</type>
<category>
<coding>
<system
value="http://hl7.eu/fhir/ig/gravitate-health/CodeSystem/epicategory-cs"/>
<code value="R"/>
<display value="Raw"/>
</coding>
</category>
<subject>
<reference
value="MedicinalProductDefinition/mp04c5df8b1b688f62331c672bbd9ffa97"/>
</subject>
<date value="2022-02-16T13:28:17Z"/>
<author>
<reference
value="Organization/mah-d21dfe8c15312e8b8bf0b7774b510a9d"/>
</author>
<title value="TEST PURPOSES ONLY - Calcichew-D3 Forte"/>
<attester>
<mode>
<coding>
<system
value="http://hl7.org/fhir/composition-attestation-mode"/>
<code value="official"/>
</coding>
</mode>
<time value="2022-02-16T13:28:17Z"/>
</attester>
<section>
<title value="B. Package Leaflet"/>
<code>
<coding>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<code value="100000155538"/>
</coding>
<text value="B. Package Leaflet"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml">unavailable</div>
</text>
<emptyReason>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/list-empty-reason"/>
<code value="unavailable"/>
</coding>
</emptyReason>
<section>
<title value="Package leaflet: Information for the user"/>
<code>
<coding>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<code value="100000155538"/>
</coding>
<text value="Package leaflet: Information for the user"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>PATIENT INFORMATION LEAFLET</p><p>CALCICHEW*-D3 FORTE 500 mg/400 IU CHEWABLE TABLETS calcium/colecalciferol</p><p>Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. - Always take this medicine exactly as described in this leaflet or as your pharmacist has told you.<br/>- Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - You must talk to a doctor if you do not feel better or if you feel worse after two weeks. - If you get any side effects talk to your pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.</p></div>
</text>
</section>
<section>
<title value="What is in this leaflet"/>
<code>
<coding>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<code value="100000155538"/>
</coding>
<text value="What is in this leaflet"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>What is in this leaflet:<br/>1. What Calcichew-D3 Forte is and what it is used for 2. What you need to know before you take Calcichew-D3 Forte<br/>3. How to take Calcichew-D3 Forte<br/>4. Possible side effects 5. How to store Calcichew-D3 Forte<br/>6. Contents of the pack and other information</p></div>
</text>
</section>
<section>
<title
value="1. What Calcichew-D3 Forte is and what it is used for"/>
<code>
<coding>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<code value="100000155538"/>
</coding>
<text
value="1. What Calcichew-D3 Forte is and what it is used for"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>WHAT CALCICHEW- D3 FORTE IS AND WHAT IT IS USED FOR</p><p>Calcichew-D3 Forte Chewable Tablets are lemon flavoured chewable tablets containing calcium and vitamin D3 which are both important substances in bone formation. Both are found in the diet and vitamin D is also produced in the skin after exposure to the sun.</p><p>Calcichew-D3 Forte is used to treat and prevent vitamin D/calcium deficiency, which may occur when your diet or lifestyle does not provide enough, or when body requirements are increased. This medicine may also be prescribed or recommended for certain bone conditions, for example osteoporosis, or during pregnancy.</p></div>
</text>
</section>
<section>
<title
value="2. What you need to know before you take Calcichew-D3 Forte"/>
<code>
<coding>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<code value="100000155538"/>
</coding>
<text
value="2. What you need to know before you take Calcichew-D3 Forte"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>WHAT YOU NEED TO KNOW BEFORE YOU TAKE CALCICHEW- D3 FORTE</p><p>Do not take Calcichew- D3 Forte if you: • are allergic to calcium, vitamin D, or any of the other ingredients of this medicine (listed in section 6)<br/>• have severe kidney problems<br/>• have a condition that causes excessive amounts of calcium in your blood or urine<br/>(hypercalcaemia or hypercalciuria) e.g. o renal (kidney) failure o cancer that has affected your bones • have excessive amounts of vitamin D in your blood • have kidney stones.</p><p>Warnings and precautions Talk to your doctor or pharmacist before taking Calcichew- D3 Forte: • if you have osteoporosis (brittle bones) and are also unable to move around • if you are on long term treatment, especially if you are taking medicines for a heart disorder (cardiac glycosides), or diuretics (used in the treatment of high blood pressure or oedema) • if you have signs of impaired kidney function or a high tendency to kidney stone (calculus) formation • if you have cancer or any other conditions that may have affected your bones • if you have sarcoidosis (an immune system disorder which may cause increased levels of vitamin D in the body).</p><p>If you have any of the following conditions your serum calcium or phosphate levels, or urinary calcium excretion must be monitored. Calcichew should be taken under close medical supervision. • sarcoidosis (an immune system disorder which may affect your liver, lungs, skin or lymph nodes) • kidney problems<br/>• you are on long-term treatment with Calcichew • you are already taking additional doses of calcium or vitamin D.</p><p>If you have increased calcium levels in the blood or develop signs of kidney problems, the dose of Calcichew-D3 Forte should be reduced or the treatment discontinued.</p><p>Other medicines and Calcichew- D3 Forte Tell your pharmacist if you are taking, have recently taken or might take any other medicines.</p><p>In particular, the following medicines may interact with Calcichew-D3 Forte chewable tablets: * thiazide diuretics (water tablets); your serum calcium levels should be monitored regularly. * cardiac glycosides (heart medicines); you should be monitored by electrocardiogram (ECG) and your serum calcium levels measured. * tetracycline antibiotics; these should be taken at least two hours before, or four to six hours afterwards. Calcium carbonate may interfere with the absorption of tetracycline preparations if taken at the same time.<br/><em>levothyroxine (hormone used to treat thyroid deficiency); these should be taken at least four hours before or after taking Calcichew- D3 Forte<br/></em>quinolone antibiotics (ciprofloxacin, lomefloxacin, norfloxacin, sparfloxacin): the effect of these medicines may be reduced if taken at the same time as calcium. Take quinolone antibiotics two hours before or six hours after taking Calcichew- D3 Forte. * bisphosphonates; should be taken at least one hour before Calcichew-D3 Forte * Calcium salts may decrease the absorption of iron, zinc and strontium ranelate. Consequently iron, zinc or strontium ranelate preparations should be taken at least two hours before or after Calcichew-D3 Forte<br/>* Orlistat (used to treat obesity) may disturb the absorption of fat-soluble vitamins, e.g. vitamin D3.</p><p>If you are taking any of the above-mentioned medicines, your pharmacist will give you further instructions.</p><p>Taking Calcichew-D3 Forte with food and drink Calcichew-D3 Forte can be taken with or without food and drink.</p><p>Pregnancy and breast-feeding If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your pharmacist for advice before taking Calcichew-D3 Forte.</p><p>If you are pregnant, you may use Calcichew-D3 Forte in case of a calcium and vitamin D deficiency. During pregnancy you should not take more than 2500 mg calcium and 4000 IU vitamin D per day, as overdoses may harm the unborn child.</p><p>Calcichew-D3 Forte can be used during breast-feeding. Calcium and vitamin D3 pass into breast milk. This should be considered when giving additional vitamin D to the child.</p><p>Driving and using machines Calcichew- D3 Forte has no known influence on the ability to drive or use machines.</p><p>Calcichew- D3 Forte contains isomalt and sucrose.<br/>Calcichew-D3 Forte contains isomalt (E953) and sucrose (E420): if you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine. May be harmful to teeth.</p></div>
</text>
</section>
<section>
<title value="3. How to take Calcichew-D3 Forte"/>
<code>
<coding>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<code value="100000155538"/>
</coding>
<text value="3. How to take Calcichew-D3 Forte"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>HOW TO TAKE CALCICHEW- D3 FORTE</p><p>Always take Calcichew- D3 Forte Tablets exactly as described in this leaflet or as your pharmacist has told you. Check with your pharmacist if you are not sure.</p><p>Dosage The recommended dose is two tablets a day, preferably one tablet in the morning and one tablet in the evening. The tablet may be chewed or sucked.</p><p>Children Calcichew-D3 Forte chewable tablets are not recommended for use in children</p><p>If you take more than you should If you have taken more Calcichew- D3 Forte than you should, talk to your pharmacist immediately.</p><p>If you forget to take Calcichew- D3 Forte Chewable Tablets Do not take a double dose to make up for a forgotten tablet.</p><p>If you have any further questions on the use of this medicine, ask your pharmacist.</p></div>
</text>
</section>
<section>
<title value="4. Possible side effects"/>
<code>
<coding>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<code value="100000155538"/>
</coding>
<text value="4. Possible side effects"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>POSSIBLE SIDE EFFECTS</p><p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>Stop taking your medicine and see a doctor immediately if you experience: •<br/>Frequent urge to urinate * Headache •<br/>Loss of appetite, nausea or vomiting •<br/>Unusual tiredness or weakness, along with elevated levels of calcium in the blood and kidney impairment</p><p>Side effects may include:</p><p>Uncommon side effects (may affect up to 1 in 100 people): * excessive amounts of calcium in your blood (hypercalcaemia) or in your urine (hypercalcuria) may occur with large doses</p><p>Rare side effects (may affect up to 1 in 1,000 people): * nausea * stomach ache * constipation * heartburn (dyspepsia) * diarrhoea * wind (flatulence) * rash * hives * itching</p><p>Very rare side effects (may affect up to 1 in 10,000 people): * Milk alkali syndrome (also called Burnett’s Syndrome and usually only seen when excessive amounts of calcium have been ingested), symptoms are frequent urge to urinate, headache, loss of appetite, nausea or vomiting, unusual tiredness or weakness, along with elevated levels of calcium in the blood and kidney impairment.</p><p>Not known (frequency cannot be estimated from the available data):<br/>* Hypersensitivity reactions such as swelling of the face, tongue, lips (angioedema) or swelling of the throat (laryngeal oedema). * If you have impaired renal function, you may be at risk of increased amounts of phosphate in the blood, renal stone formation and increased amounts of calcium in the kidneys.</p><p>Reporting of side effects If you get any side effects, talk to your pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.</p></div>
</text>
</section>
<section>
<title value="5. How to store Calcichew-D3 Forte"/>
<code>
<coding>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<code value="100000155538"/>
</coding>
<text value="5. How to store Calcichew-D3 Forte"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>HOW TO STORE CALCICHEW-D3 FORTE</p><p>Keep out of the sight and reach of children.</p><p>Store in the original package. Keep the container tightly closed to protect from moisture. Do not store above 30°C</p><p>Do not use Calcichew- D3 Forte Tablets after the expiry date which is stated on the label after EXP. The expiry date refers to the last day of that month. If the tablets have changed shape or colour do not use.</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p></div>
</text>
</section>
<section>
<title value="6. Contents of the pack and other information"/>
<code>
<coding>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<code value="100000155538"/>
</coding>
<text value="6. Contents of the pack and other information"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>CONTENTS OF THE PACK AND OTHER INFORMATION</p><p>What Calcichew-D3 Forte Chewable Tablets contain The active ingredients in each tablet are: • 1250mg calcium carbonate (equivalent to 500mg calcium) • 400IU colecalciferol (equivalent to 10 micrograms vitamin D3)</p><p>The other ingredients are: xylitol (E967), povidone, isomalt (E953), fatty acid mono- and di- glycerides, magnesium stearate, lemon flavour, sucralose (E955), sucrose, tocopherol, modified maize starch, medium-chain triglycerides, sodium ascorbate and anhydrous colloidal silica (see also end of Section 2 “Calcichew-D3 Forte contains isomalt and sucrose”).</p><p>What Calcichew-D3 Forte look like and contents of the pack The tablets are round, white, uncoated, convex and lemon flavoured; they may have small specks. The tablets are packed in white, plastic bottles of 60 and 100 tablets. Not all pack sizes may be marketed.</p><p>Marketing Authorisation Holder<br/>Neon Healthcare Ltd., 8 The Chase, John Tate Road, Hertford, SG13 7NN, UK</p><p>Manufacturer Asker Contract Manufacturing AS, Drammensveien 852, N-1385 Asker, Norway.</p><p>This leaflet was last revised in March 2023.<br/>Additional Information<br/>Calcichew-D3 Forte are a combination of calcium and vitamin D designed to keep bones healthy. Calcium is an essential component of bones while vitamin D plays an important role in the absorption of calcium from food.</p><p>Requirements for calcium increase with age and, although many people obtain enough calcium from their diet, some people may require a supplement in order that their body has all the calcium it needs to maintain healthy bones. Vitamin D is produced largely from the action of sunlight. Certain foodstuffs do contain vitamin D in reasonable amounts but it is not always possible to obtain all the vitamin D you need from your diet. People who do not get out and about, for instance those who are housebound or people living in nursing and residential homes, may not receive all the vitamin D they need.</p><p>People with diets and lifestyles that mean they will obtain less than the recommended intake of calcium and vitamin D are at risk of weakened bones. Prolonged lack of adequate calcium and vitamin D intake can lead to the development of osteoporosis, a condition where bones become weak to a level that minimal trauma (for example, a fall) can result in a fracture, most typically at the hip, spine or wrist.</p><p>Calcichew-D3 Forte have been designed to give people whose intakes of calcium and vitamin D are low a boost to the recommended amounts.</p><p>Maintaining healthy bones and helping to avoid osteoporosis is an important issue for many people. There are many ways that people can help themselves: regular exercise, a balanced diet with an adequate intake of calcium and vitamin D and, for some people, advice on how to prevent falls which may lead to fracture.</p><p>The Royal Osteoporosis Society is a national charity dedicated to improving the diagnosis, prevention and treatment of osteoporosis. The Royal Osteoporosis Society offers support to people with osteoporosis and raises awareness of the importance of healthy bones.</p><p>If you are concerned about osteoporosis, please contact the Royal Osteoporosis Society, Camerton, Bath BA2 0PJ. Tel: 01761 471 771 or email: info@theros.org.uk.<br/>*Registered Trademark</p></div>
</text>
</section>
</section>
</Composition>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-calchichewd3f-calciumcarbonate"/>
<resource>
<Ingredient>
<id value="ingredient-for-calchichewd3f-calciumcarbonate"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_ingredient-for-calchichewd3f-calciumcarbonate"> </a><p><b>Generated Narrative: Ingredient</b><a name="ingredient-for-calchichewd3f-calciumcarbonate"> </a><a name="hcingredient-for-calchichewd3f-calciumcarbonate"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceIngredient "ingredient-for-calchichewd3f-calciumcarbonate" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/H0G9379FGK (use: official)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li>See on this page: ManufacturedItemDefinition/mid-a64c0ccb066e7fdf6ba2d86dcd8bda5e</li><li>See on this page: MedicinalProductDefinition/mp04c5df8b1b688f62331c672bbd9ffa97</li><li>See on this page: AdministrableProductDefinition/ap-a64c0ccb066e7fdf6ba2d86dcd8bda5e</li></ul><p><b>role</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072072)</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>Calcium Carbonate <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#H0G9379FGK)</span></td></tr></table><h3>Strengths</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Presentation[x]</b></td><td><b>Basis</b></td></tr><tr><td style="display: none">*</td><td>2500 mg<span style="background: LightGoldenRodYellow"> (Details: UCUM code mg = 'mg')</span></td><td>active ingredient - basis of strength <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.5.0/CodeSystem-v3-RoleClass.html">RoleClass</a>#ACTIB)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="H0G9379FGK"/>
</identifier>
<status value="active"/>
<for>
<reference
value="ManufacturedItemDefinition/mid-a64c0ccb066e7fdf6ba2d86dcd8bda5e"/>
</for>
<for>
<reference
value="MedicinalProductDefinition/mp04c5df8b1b688f62331c672bbd9ffa97"/>
</for>
<for>
<reference
value="AdministrableProductDefinition/ap-a64c0ccb066e7fdf6ba2d86dcd8bda5e"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000072072"/>
<display value="Active"/>
</coding>
</role>
<substance>
<code>
<concept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="H0G9379FGK"/>
<display value="Calcium Carbonate"/>
</coding>
</concept>
</code>
<strength>
<presentationQuantity>
<value value="2500"/>
<system value="http://unitsofmeasure.org"/>
<code value="mg"/>
</presentationQuantity>
<basis>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-RoleClass"/>
<code value="ACTIB"/>
<display value="active ingredient - basis of strength"/>
</coding>
</basis>
</strength>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-calchichewd3f-cholecalciferol"/>
<resource>
<Ingredient>
<id value="ingredient-for-calchichewd3f-cholecalciferol"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_ingredient-for-calchichewd3f-cholecalciferol"> </a><p><b>Generated Narrative: Ingredient</b><a name="ingredient-for-calchichewd3f-cholecalciferol"> </a><a name="hcingredient-for-calchichewd3f-cholecalciferol"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceIngredient "ingredient-for-calchichewd3f-cholecalciferol" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/1C6V77QF41 (use: official)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li>See on this page: ManufacturedItemDefinition/mid-a64c0ccb066e7fdf6ba2d86dcd8bda5e</li><li>See on this page: MedicinalProductDefinition/mp04c5df8b1b688f62331c672bbd9ffa97</li><li>See on this page: AdministrableProductDefinition/ap-a64c0ccb066e7fdf6ba2d86dcd8bda5e</li></ul><p><b>role</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072072)</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>cholecalciferol <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#1C6V77QF41)</span></td></tr></table><h3>Strengths</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Presentation[x]</b></td><td><b>Basis</b></td></tr><tr><td style="display: none">*</td><td>22 ug<span style="background: LightGoldenRodYellow"> (Details: UCUM code ug = 'ug')</span></td><td>active ingredient - basis of strength <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.5.0/CodeSystem-v3-RoleClass.html">RoleClass</a>#ACTIB)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="1C6V77QF41"/>
</identifier>
<status value="active"/>
<for>
<reference
value="ManufacturedItemDefinition/mid-a64c0ccb066e7fdf6ba2d86dcd8bda5e"/>
</for>
<for>
<reference
value="MedicinalProductDefinition/mp04c5df8b1b688f62331c672bbd9ffa97"/>
</for>
<for>
<reference
value="AdministrableProductDefinition/ap-a64c0ccb066e7fdf6ba2d86dcd8bda5e"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000072072"/>
<display value="Active"/>
</coding>
</role>
<substance>
<code>
<concept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="1C6V77QF41"/>
<display value="cholecalciferol"/>
</coding>
</concept>
</code>
<strength>
<presentationQuantity>
<value value="22"/>
<system value="http://unitsofmeasure.org"/>
<code value="ug"/>
</presentationQuantity>
<basis>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-RoleClass"/>
<code value="ACTIB"/>
<display value="active ingredient - basis of strength"/>
</coding>
</basis>
</strength>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/AdministrableProductDefinition/ap-a64c0ccb066e7fdf6ba2d86dcd8bda5e"/>
<resource>
<AdministrableProductDefinition>
<id value="ap-a64c0ccb066e7fdf6ba2d86dcd8bda5e"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/AdministrableProductDefinition-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="AdministrableProductDefinition_ap-a64c0ccb066e7fdf6ba2d86dcd8bda5e"> </a><p><b>Generated Narrative: AdministrableProductDefinition</b><a name="ap-a64c0ccb066e7fdf6ba2d86dcd8bda5e"> </a><a name="hcap-a64c0ccb066e7fdf6ba2d86dcd8bda5e"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceAdministrableProductDefinition "ap-a64c0ccb066e7fdf6ba2d86dcd8bda5e" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-AdministrableProductDefinition-uv-epi.html">AdministrableProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/gh-1</p><p><b>status</b>: active</p><p><b>formOf</b>: See on this page: MedicinalProductDefinition/mp04c5df8b1b688f62331c672bbd9ffa97</p><p><b>administrableDoseForm</b>: Chewable tablet <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073684)</span></p><p><b>unitOfPresentation</b>: Tablet <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000002152)</span></p><p><b>producedFrom</b>: See on this page: ManufacturedItemDefinition/mid-a64c0ccb066e7fdf6ba2d86dcd8bda5e</p><blockquote><p><b>routeOfAdministration</b></p><p><b>code</b>: Oral use <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073619)</span></p><h3>TargetSpecies</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Code</b></td></tr><tr><td style="display: none">*</td><td>Human <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000109093)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="gh-1"/>
</identifier>
<status value="active"/>
<formOf>
<reference
value="MedicinalProductDefinition/mp04c5df8b1b688f62331c672bbd9ffa97"/>
</formOf>
<administrableDoseForm>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000073684"/>
<display value="Chewable tablet"/>
</coding>
</administrableDoseForm>
<unitOfPresentation>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="200000002152"/>
<display value="Tablet"/>
</coding>
</unitOfPresentation>
<producedFrom>
<reference
value="ManufacturedItemDefinition/mid-a64c0ccb066e7fdf6ba2d86dcd8bda5e"/>
</producedFrom>
<routeOfAdministration>
<code>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000073619"/>
<display value="Oral use"/>
</coding>
</code>
<targetSpecies>
<code>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000109093"/>
<display value="Human"/>
</coding>
</code>
</targetSpecies>
</routeOfAdministration>
</AdministrableProductDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/RegulatedAuthorization/authorizationa64c0ccb066e7fdf6ba2d86dcd8bda5e0"/>
<resource>
<RegulatedAuthorization>
<id value="authorizationa64c0ccb066e7fdf6ba2d86dcd8bda5e0"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="RegulatedAuthorization_authorizationa64c0ccb066e7fdf6ba2d86dcd8bda5e0"> </a><p><b>Generated Narrative: RegulatedAuthorization</b><a name="authorizationa64c0ccb066e7fdf6ba2d86dcd8bda5e0"> </a><a name="hcauthorizationa64c0ccb066e7fdf6ba2d86dcd8bda5e0"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceRegulatedAuthorization "authorizationa64c0ccb066e7fdf6ba2d86dcd8bda5e0" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-RegulatedAuthorization-uv-epi.html">RegulatedAuthorization (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/gh-1 (use: official)</p><p><b>subject</b>: See on this page: MedicinalProductDefinition/mp04c5df8b1b688f62331c672bbd9ffa97</p><p><b>type</b>: Marketing Authorisation <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#220000000061)</span></p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2015-02-07 13:28:17+0000</p><p><b>holder</b>: See on this page: Organization/mah-d21dfe8c15312e8b8bf0b7774b510a9d</p></div>
</text>
<identifier>
<use value="official"/>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="gh-1"/>
</identifier>
<subject>
<reference
value="MedicinalProductDefinition/mp04c5df8b1b688f62331c672bbd9ffa97"/>
</subject>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="220000000061"/>
<display value="Marketing Authorisation"/>
</coding>
</type>
<status>
<coding>
<system value="http://hl7.org/fhir/publication-status"/>
<code value="active"/>
<display value="Active"/>
</coding>
</status>
<statusDate value="2015-02-07T13:28:17Z"/>
<holder>
<reference
value="Organization/mah-d21dfe8c15312e8b8bf0b7774b510a9d"/>
</holder>
</RegulatedAuthorization>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/Organization/mah-d21dfe8c15312e8b8bf0b7774b510a9d"/>
<resource>
<Organization>
<id value="mah-d21dfe8c15312e8b8bf0b7774b510a9d"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Organization_mah-d21dfe8c15312e8b8bf0b7774b510a9d"> </a><p><b>Generated Narrative: Organization</b><a name="mah-d21dfe8c15312e8b8bf0b7774b510a9d"> </a><a name="hcmah-d21dfe8c15312e8b8bf0b7774b510a9d"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceOrganization "mah-d21dfe8c15312e8b8bf0b7774b510a9d" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Organization-uv-epi.html">Organization (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/omswi</code>/xx (use: official)</p><p><b>active</b>: true</p><p><b>type</b>: Marketing authorisation holder <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#220000000034)</span></p><p><b>name</b>: Neon Healthcare Ltd</p><h3>Contacts</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Address</b></td></tr><tr><td style="display: none">*</td><td>8 The Chase, John Tate Road, Foxholes Business Park, Hertford Hertfordshire UK(work)</td></tr></table></div>
</text>
<identifier>
<use value="official"/>
<system value="https://spor.ema.europa.eu/omswi"/>
<value value="xx"/>
</identifier>
<active value="true"/>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="220000000034"/>
<display value="Marketing authorisation holder"/>
</coding>
</type>
<name value="Neon Healthcare Ltd"/>
<contact>
<address>
<use value="work"/>
<type value="physical"/>
<text
value="8 The Chase, John Tate Road, Foxholes Business Park, Hertford Hertfordshire UK"/>
<line
value="8 The Chase, John Tate Road, Foxholes Business Park, Hertford"/>
<city value="Hertfordshire"/>
<country value="UK"/>
</address>
</contact>
</Organization>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/PackagedProductDefinition/ppd-a46ff5cb1a9568d59a1669fd597f58bf"/>
<resource>
<PackagedProductDefinition>
<id value="ppd-a46ff5cb1a9568d59a1669fd597f58bf"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="PackagedProductDefinition_ppd-a46ff5cb1a9568d59a1669fd597f58bf"> </a><p><b>Generated Narrative: PackagedProductDefinition</b><a name="ppd-a46ff5cb1a9568d59a1669fd597f58bf"> </a><a name="hcppd-a46ff5cb1a9568d59a1669fd597f58bf"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourcePackagedProductDefinition "ppd-a46ff5cb1a9568d59a1669fd597f58bf" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-PackagedProductDefinition-uv-epi.html">PackagedProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/gh-1 (use: official)</p><p><b>name</b>: Calcichew-D3 Forte 28</p><p><b>type</b>: Chemical Medicinal Product <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000155527)</span></p><p><b>packageFor</b>: See on this page: MedicinalProductDefinition/mp04c5df8b1b688f62331c672bbd9ffa97</p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2015-02-07 13:28:17+0000</p><blockquote><p><b>packaging</b></p><p><b>type</b>: Box <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073498)</span></p><p><b>quantity</b>: 1</p><p><b>material</b>: Cardboard <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000003529)</span></p><blockquote><p><b>packaging</b></p><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/123456</p><p><b>type</b>: Blister <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073496)</span></p><p><b>quantity</b>: 28</p><p><b>material</b>: PolyVinyl Chloride <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000003222)</span></p><blockquote><p><b>containedItem</b></p></blockquote></blockquote></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="gh-1"/>
</identifier>
<name value="Calcichew-D3 Forte 28"/>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000155527"/>
<display value="Chemical Medicinal Product"/>
</coding>
</type>
<packageFor>
<reference
value="MedicinalProductDefinition/mp04c5df8b1b688f62331c672bbd9ffa97"/>
</packageFor>
<status>
<coding>
<system value="http://hl7.org/fhir/publication-status"/>
<code value="active"/>
<display value="Active"/>
</coding>
</status>
<statusDate value="2015-02-07T13:28:17Z"/>
<packaging>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000073498"/>
<display value="Box"/>
</coding>
</type>
<quantity value="1"/>
<material>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="200000003529"/>
<display value="Cardboard"/>
</coding>
</material>
<packaging>
<identifier>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="123456"/>
</identifier>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000073496"/>
<display value="Blister"/>
</coding>
</type>
<quantity value="28"/>
<material>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="200000003222"/>
<display value="PolyVinyl Chloride"/>
</coding>
</material>
<containedItem>
<item>
<reference>
<reference
value="ManufacturedItemDefinition/mid-a64c0ccb066e7fdf6ba2d86dcd8bda5e"/>
</reference>
</item>
</containedItem>
</packaging>
</packaging>
</PackagedProductDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/MedicinalProductDefinition/mp04c5df8b1b688f62331c672bbd9ffa97"/>
<resource>
<MedicinalProductDefinition>
<id value="mp04c5df8b1b688f62331c672bbd9ffa97"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/MedicinalProductDefinition-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="MedicinalProductDefinition_mp04c5df8b1b688f62331c672bbd9ffa97"> </a><p><b>Generated Narrative: MedicinalProductDefinition</b><a name="mp04c5df8b1b688f62331c672bbd9ffa97"> </a><a name="hcmp04c5df8b1b688f62331c672bbd9ffa97"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceMedicinalProductDefinition "mp04c5df8b1b688f62331c672bbd9ffa97" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-MedicinalProductDefinition-uv-epi.html">MedicinalProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>http://fakesys.com/ids</code>/gh-1</p><p><b>type</b>: Medicinal Product <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-medicinal-product-type.html">Medicinal Product Type</a>#MedicinalProduct)</span></p><p><b>domain</b>: Human use <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-medicinal-product-domain.html">Medicinal Product Domain</a>#Human)</span></p><p><b>status</b>: active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>legalStatusOfSupply</b>: Medicinal product subject to medical prescription <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072084)</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: Calcichew-D3 Forte</p><p><b>type</b>: Full name <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000001)</span></p><blockquote><p><b>part</b></p><p><b>part</b>: Calcichew-D3 Forte</p><p><b>type</b>: Invented name part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000002)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: calcium/colecalciferol</p><p><b>type</b>: Scientific name part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000003)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: 500 mg/400 IU</p><p><b>type</b>: Strength part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000004)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: CHEWABLE TABLETS</p><p><b>type</b>: Pharmaceutical dose form part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000005)</span></p></blockquote><h3>Usages</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Country</b></td><td><b>Jurisdiction</b></td><td><b>Language</b></td></tr><tr><td style="display: none">*</td><td>United Kingdom <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.5.0/CodeSystem-ISO3166Part1.html">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#UK)</span></td><td>United Kingdom <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.5.0/CodeSystem-ISO3166Part1.html">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#UK)</span></td><td>English <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.5.0/CodeSystem-v3-ietf3066.html">Tags for the Identification of Languages</a>#en)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<system value="http://fakesys.com/ids"/>
<value value="gh-1"/>
</identifier>
<type>
<coding>
<system value="http://hl7.org/fhir/medicinal-product-type"/>
<code value="MedicinalProduct"/>
<display value="Medicinal Product"/>
</coding>
</type>
<domain>
<coding>
<system value="http://hl7.org/fhir/medicinal-product-domain"/>
<code value="Human"/>
<display value="Human use"/>
</coding>
</domain>
<status>
<coding>
<system value="http://hl7.org/fhir/publication-status"/>
<code value="active"/>
<display value="active"/>
</coding>
</status>
<legalStatusOfSupply>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000072084"/>
<display
value="Medicinal product subject to medical prescription"/>
</coding>
</legalStatusOfSupply>
<name>
<productName value="Calcichew-D3 Forte"/>
<type>
<coding>
<system value="https://spor.ema.europa.eu/lists/220000000000"/>
<code value="220000000001"/>
<display value="Full name"/>
</coding>
</type>
<part>
<part value="Calcichew-D3 Forte"/>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/lists/220000000000"/>
<code value="220000000002"/>
<display value="Invented name part"/>
</coding>
</type>
</part>
<part>
<part value="calcium/colecalciferol"/>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/lists/220000000000"/>
<code value="220000000003"/>
<display value="Scientific name part"/>
</coding>
</type>
</part>
<part>
<part value="500 mg/400 IU"/>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/lists/220000000000"/>
<code value="220000000004"/>
<display value="Strength part"/>
</coding>
</type>
</part>
<part>
<part value="CHEWABLE TABLETS"/>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/lists/220000000000"/>
<code value="220000000005"/>
<display value="Pharmaceutical dose form part"/>
</coding>
</type>
</part>
<usage>
<country>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="UK"/>
<display value="United Kingdom"/>
</coding>
</country>
<jurisdiction>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="UK"/>
<display value="United Kingdom"/>
</coding>
</jurisdiction>
<language>
<coding>
<system value="urn:ietf:bcp:47"/>
<code value="en"/>
<display value="English"/>
</coding>
</language>
</usage>
</name>
</MedicinalProductDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/ManufacturedItemDefinition/mid-a64c0ccb066e7fdf6ba2d86dcd8bda5e"/>
<resource>
<ManufacturedItemDefinition>
<id value="mid-a64c0ccb066e7fdf6ba2d86dcd8bda5e"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ManufacturedItemDefinition-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ManufacturedItemDefinition_mid-a64c0ccb066e7fdf6ba2d86dcd8bda5e"> </a><p><b>Generated Narrative: ManufacturedItemDefinition</b><a name="mid-a64c0ccb066e7fdf6ba2d86dcd8bda5e"> </a><a name="hcmid-a64c0ccb066e7fdf6ba2d86dcd8bda5e"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceManufacturedItemDefinition "mid-a64c0ccb066e7fdf6ba2d86dcd8bda5e" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ManufacturedItemDefinition-uv-epi.html">ManufacturedItemDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/gh-1 (use: official)</p><p><b>status</b>: active</p><p><b>manufacturedDoseForm</b>: Chewable tablet <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#100000073684)</span></p><p><b>unitOfPresentation</b>: Tablet <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000002152)</span></p></div>
</text>
<identifier>
<use value="official"/>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="gh-1"/>
</identifier>
<status value="active"/>
<manufacturedDoseForm>
<coding>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<code value="100000073684"/>
<display value="Chewable tablet"/>
</coding>
</manufacturedDoseForm>
<unitOfPresentation>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="200000002152"/>
<display value="Tablet"/>
</coding>
</unitOfPresentation>
</ManufacturedItemDefinition>
</resource>
</entry>
</Bundle>
IG © 2021+ Gravitate Health Project. Package hl7.eu.fhir.gh#0.1.0 based on FHIR 5.0.0. Generated 2024-05-15
Links: Table of Contents |
QA Report
The Gravitate Health project has received funding from the IMI 2 Joint Undertaking under grant agreement No 945334.
This joint undertaking receives support from the EU H2020 research and innovation programme and EFPIA.
